<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941110-0-00022</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> November 10, 1994 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> <!-- PJG STAG 4700 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <CFRNO>21 CFR Parts 520 and 522</CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Animal Drugs, Feeds, and Related Products; Change of Sponsor <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Final rule. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for eight new animal drug applications (NADA's) from Hoffmann-La Roche, Inc., to SmithKline Beecham Animal Health. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> November 10, 1994 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Benjamin A. Puyot, Center for Veterinary Medicine (HFV&hyph;130), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1646. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Hoffmann-LaRoche, Inc., Nutley, NJ 07110, has informed FDA that it has transferred ownership of, and all rights and interests in, the following approved NADA's to SmithKline Beecham Animal Health, 1600 Paoli Pike, West Chester, PA 19380: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 3,L2,nj,i1,s1,32L,32L -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1NADA Number  <!-- PJG 007 0150 intable --> 1Ingredient  <!-- PJG 007 0150 intable --> 1Trade name  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=01 g=1 f=1 --> 15&hyph;102  <!-- PJG 007 0104 intable --> Sulfadimethoxine <!-- PJG 007 0104 intable --> Albon Tablets <!-- PJG 0012 frnewline --> 31&hyph;205  <!-- PJG 007 0104 intable --> Sulfadimethoxine  <!-- PJG 007 0104 intable --> Albon Drinking Water Solution <!-- PJG 0012 frnewline --> 31&hyph;715  <!-- PJG 007 0104 intable --> Sulfadimethoxine  <!-- PJG 007 0104 intable --> Albon Bolus <!-- PJG 0012 frnewline --> 41&hyph;245  <!-- PJG 007 0104 intable --> Sulfadimethoxine  <!-- PJG 007 0104 intable --> Albon Injection 40% <!-- PJG 0012 frnewline --> 43&hyph;785  <!-- PJG 007 0104 intable --> Sulfadimethoxine  <!-- PJG 007 0104 intable --> Albon Oral Suspension 5% <!-- PJG 0012 frnewline --> 46&hyph;285  <!-- PJG 007 0104 intable --> Sulfadimethoxine  <!-- PJG 007 0104 intable --> Albon Soluble Powder <!-- PJG 0012 frnewline --> 93&hyph;107  <!-- PJG 007 0104 intable --> Sulfadimethoxine  <!-- PJG 007 0104 intable --> Albon Sustained-Release Bolus <!-- PJG 0012 frnewline --> 100&hyph;929  <!-- PJG 007 0104 intable --> Sulfadimethoxine/ormetoprim  <!-- PJG 007 0104 intable --> Primor Tablets <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Accordingly, the agency is amending the regulations in 21 CFR 520.2220a(b), 520.2220b(b)(1), 520.2220c(c), 520.2220d(b) and 522.2220(a)(2)(i) to reflect the change of sponsor. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> 21 CFR Part 520 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Animal drugs. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> 21 CFR Part 522 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Animal drugs. <!-- PJG 0012 frnewline --> Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 520 and 522 are amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 520_ORAL DOSAGE FORM NEW ANIMAL DRUGS <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. The authority citation for 21 CFR part 520 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;520.2220a  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Amended] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 520.2220a  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sulfadimethoxine oral solution and soluble powder <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is amended in paragraph (b) by removing ``000004'' and by adding in its place ``053571''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;520.2220b  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Amended] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 3. Section 520.2220b  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sulfadimethoxine tablets and boluses <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is amended in paragraph (b)(1) by removing ``000004'' and by adding in its place ``053571''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;520.2220c <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Amended] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 4. Section 520.2220c  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sulfadimethoxine oral suspension <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is amended in paragraph (c) by removing ``000004'' and by adding in its place ``053571''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;520.2220d  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Amended] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 5. Section 520.2220d  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sulfadimethoxine-ormetoprim tablets <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is amended in paragraph (b) by removing ``000004'' and by adding in its place ``053571''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 6. The authority citation of 21 CFR part 522 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=24 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=4 --> Authority:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;522.2220 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Amended] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 7. Section 522.2220  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sulfadimethoxine injection <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is amended in paragraph (a)(2)(i) by removing ``000004'' and by adding in its place ``053571''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: November 2, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Robert C. Livingston, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;27793 Filed 11&hyph;9&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            